Carnegie Investment Counsel’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,380
Closed -$252K 307
2014
Q4
$252K Buy
2,380
+18
+0.8% +$1.73K 0.05% 247
2014
Q3
$204K Buy
+2,362
New +$209K 0.04% 282

Carnegie Investment Counsel's COV Position: Q1 2015 in Review

Carnegie Investment Counsel sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,380 shares — an estimated $252K sold.

Carnegie Investment Counsel first reported a position in COV in Q3 2014 and held it in 2 quarters. The position peaked at $252K in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Carnegie Investment Counsel reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Carnegie Investment Counsel sold 2,380 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $252K.
  • Carnegie Investment Counsel first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014 and held it in 2 quarters.
  • Carnegie Investment Counsel's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $252K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Carnegie Investment Counsel's 13F filing for Q1 2015, filed 5 May 2015.